logically
symptomatic individuals. Moreover, the magnitude of
beneﬁt depends on the assumption that interventions
are performed with minimal morbidity. Populationlevel screening for asymptomatic carotid artery disease
is not currently recommended by the US Preventive Services Task Force.29 The identiﬁcation of asymptomatic
patients with “screening” should therefore be limited to
high-risk individuals (see Clinical Practice Guidelines
document), or those with relevant ﬁndings on